Medicine Description simvaxibe 10 gm
Simvaxibe 10 gm Tablets is a medication that combines ezetimibe and simvastatin, targeting cholesterol levels in the bloodstream through a dual mechanism. Ezetimibe operates by selectively inhibiting the absorption of cholesterol in the small intestine. It achieves this by binding to the Niemann-Pick C1-Like 1 (NPC1L1) protein, effectively blocking intestinal cholesterol uptake. This action results in decreased delivery of cholesterol to the liver, prompting a compensatory increase in the hepatic uptake of LDL cholesterol from the circulation. Simultaneously, simvastatin, a statin, works by inhibiting the enzyme HMG-CoA reductase, a key player in the cholesterol synthesis pathway within the liver. This dual action not only reduces intestinal cholesterol absorption but also lowers endogenous cholesterol production, leading to significant reductions in serum LDL cholesterol levels.
Indications and Uses of Simvaxibe 10 gm Tablets
- Adjunct to dietary modifications for the treatment of primary hypercholesterolemia
- Homozygous familial hypercholesterolemia as part of a comprehensive treatment plan
- Adjunct to dietary measures in patients with homozygous familial sitosterolemia
Side Effects of Simvaxibe 10 gm Tablets
- Muscle pain or weakness
- Gastrointestinal disturbances, such as diarrhea or abdominal pain
- Elevated liver enzymes
- Headache
- Rash
Storage and Handling
Store Simvaxibe 10 gm Tablets at room temperature, away from moisture and heat. Keep out of reach of children and do not use past the expiration date on the packaging.
Patient Advice and Precautions
Patients should be advised to maintain a consistent diet low in saturated fats and cholesterol. Regular monitoring of liver function and lipid levels is recommended. It is crucial to inform healthcare providers about all current medications and any history of liver disease or muscle disorders before starting treatment.